The At4g04750 Antibody is a specialized immunoglobulin designed to bind specifically to the protein encoded by the AT4G04750 gene in Arabidopsis thaliana. This gene encodes a sugar transporter ERD6-like 14, a mitochondrial F1F0-ATPase inhibitor involved in cellular stress responses and energy metabolism. The antibody serves as a critical tool for studying the gene’s expression, localization, and functional roles in plant physiology, particularly under stress conditions or genetic mutations .
Function: Encodes a mitochondrial protein with conserved roles as an endogenous inhibitor of the F1F0-ATPase, influencing cellular energy balance and stress tolerance .
Expression: Highly upregulated in rrp6l1-2 mutants (log2 fold change: 2.42, padj: 2.19 × 10⁻⁵⁰) compared to wild-type Arabidopsis under unstressed conditions, suggesting involvement in RNA metabolism or mitochondrial regulation .
Name: Sugar transporter ERD6-like 14
Uniprot ID: Q8GXK5
Source Organisms: Recombinant protein produced in yeast, E. coli, baculovirus, or mammalian cells .
Mitochondrial Function:
Genetic Mutant Analysis:
Sugar Transport Dynamics:
At4g04750 is a gene locus in Arabidopsis thaliana, following the standard Arabidopsis genome annotation format where "At" represents Arabidopsis thaliana, "4" indicates chromosome 4, and "g04750" denotes the specific gene locus. The antibodies targeting proteins encoded by Arabidopsis genes are important tools for studying plant protein function, localization, and expression patterns. Similar to other plant antibodies, those targeting the At4g04750 protein product would be developed for specific research applications in plant biology.
Antibodies in Arabidopsis research are commonly used for:
Protein detection via Western blotting
Protein localization through immunofluorescence and immunohistochemistry
Protein-protein interaction studies using co-immunoprecipitation
Chromatin immunoprecipitation (ChIP) for DNA-protein interaction analysis
Flow cytometry for cell-specific protein expression quantification
These applications allow researchers to investigate protein function, regulation, and interactions within specific cellular contexts, providing insights into plant development, stress responses, and other biological processes.
In plant research, particularly with Arabidopsis, researchers typically work with:
Monoclonal antibodies: Highly specific antibodies produced by a single B-cell clone, such as MAC207 which binds to arabinogalactan proteins from diverse plants including Arabidopsis
Polyclonal antibodies: Mixture of antibodies that recognize multiple epitopes on the target protein
Custom-developed antibodies: Specially designed for rare or novel protein targets, such as those offered by specialized suppliers
The choice between these types depends on the research question, available resources, and the nature of the target protein. Monoclonal antibodies like MAC207 provide high specificity for particular epitopes, while polyclonal antibodies may offer greater detection sensitivity across different experimental conditions.
Proper validation of plant antibodies includes:
Western blot analysis with positive and negative controls (wild-type vs. knockout/knockdown lines)
Peptide competition assays to confirm epitope specificity
Testing across multiple experimental conditions to assess robustness
Cross-reactivity testing against related proteins
Comparison with existing antibodies or tagged protein versions where available
Validation is essential since antibody performance can vary significantly depending on the experimental context. For instance, an antibody that works well in Western blotting might not perform adequately in immunolocalization studies due to differences in protein conformation or accessibility.
Cross-reactivity remains a significant challenge when working with plant antibodies. Researchers can address this through:
Conducting detailed epitope analysis to identify unique regions in the target protein
Performing pre-absorption with related proteins to remove cross-reactive antibodies
Using knockout/knockdown lines as negative controls to confirm specificity
Employing multiple antibodies targeting different epitopes of the same protein
Complementing antibody-based methods with orthogonal techniques (e.g., mass spectrometry)
For example, when working with antibodies against proteins in gene families with high sequence homology, researchers should carefully select epitopes that are unique to the target protein and validate specificity through multiple experimental approaches.
Optimizing immunoprecipitation with plant antibodies requires:
Testing different extraction buffers to maintain protein conformation while maximizing solubility
Optimizing antibody-to-protein ratios through titration experiments
Comparing different antibody immobilization methods (e.g., direct coupling vs. Protein A/G beads)
Adjusting washing stringency to balance between specificity and yield
Considering native vs. denaturing conditions based on the research question
Plant tissues present unique challenges for protein extraction due to cell walls, vacuoles, and abundant secondary metabolites that can interfere with antibody-antigen interactions. Researchers must carefully optimize these parameters for each specific antibody and experimental context.
Detection methods require different optimizations depending on protein localization:
| Protein Localization | Extraction Considerations | Fixation Method | Common Challenges |
|---|---|---|---|
| Membrane-associated | Detergent selection critical | Cross-linking fixatives preferred | Epitope masking by lipids |
| Cytosolic | Lower detergent concentrations | Precipitative fixatives effective | Diffusion during processing |
| Nuclear | Nuclear isolation buffers | Strong fixation required | Accessibility issues |
| Cell wall-associated | Enzymatic digestion often necessary | Minimal fixation to preserve epitopes | High background due to carbohydrates |
| For membrane proteins, researchers must carefully select detergents that solubilize the protein without denaturing the epitope. Additionally, membrane fractionation techniques may be necessary to enrich for the target protein before immunodetection. |
Recent advances in computational approaches include:
Deep learning models like AF2Complex that predict antibody-antigen interactions with high accuracy
Structure-based epitope prediction algorithms to identify optimal immunogenic regions
Machine learning approaches to optimize antibody design based on physicochemical properties
Molecular dynamics simulations to predict antibody binding stability
These computational tools can significantly reduce the time and resources required for antibody development and optimization. For example, AF2Complex has demonstrated 90% accuracy in predicting effective antibodies by analyzing protein sequences and modeling 3D interactions, which could be applied to plant protein research contexts .
Effective extraction protocols typically include:
Flash-freezing tissues in liquid nitrogen before processing
Including protease inhibitors to prevent epitope degradation
Using appropriate buffer systems based on the subcellular localization of the target protein
Optimizing mechanical disruption methods to balance efficiency and protein preservation
Considering protein-specific requirements (e.g., phosphatase inhibitors for phosphoproteins)
For example, when working with arabinogalactan proteins recognized by antibodies like MAC207 , researchers should avoid harsh detergents that might disrupt carbohydrate epitopes and consider specialized extraction methods that preserve glycosylation patterns.
Effective epitope selection involves:
Conducting bioinformatic analysis to identify unique sequences with favorable immunogenic properties
Avoiding regions with post-translational modifications unless specifically targeting those modifications
Considering protein secondary structure and surface accessibility
Selecting epitopes that are conserved across experimental conditions
Avoiding regions with high similarity to other proteins to minimize cross-reactivity
For plant-specific proteins, researchers should be particularly attentive to potential glycosylation sites that might interfere with antibody binding or lead to heterogeneous detection patterns .
Recommended protocols include:
For most applications: 4% paraformaldehyde in PBS for 2-4 hours, followed by graduated ethanol series
For delicate epitopes: Lower concentrations of paraformaldehyde (1-2%) or alternative fixatives like ethanol-acetic acid
For subcellular structures: Glutaraldehyde (0.1-0.5%) addition for better ultrastructure preservation
Permeabilization: Triton X-100 (0.1-0.5%) for most applications; enzymatic cell wall digestion for challenging tissues
The choice of fixation and permeabilization must be empirically determined for each antibody and tissue type. For example, some epitopes might be sensitive to aldehyde fixation, requiring alternative approaches to maintain their immunoreactivity.
Best practices include:
Storing antibodies at -20°C or -80°C in small aliquots to minimize freeze-thaw cycles
Adding stabilizing proteins (BSA or gelatin) for dilute antibody solutions
Testing antibody activity after storage periods to ensure consistent performance
Maintaining detailed records of antibody performance across different experiments
Including glycerol (30-50%) for frozen storage to prevent damage from freeze-thaw cycles
Proper storage is crucial for maintaining antibody performance over time. For example, MAC207 antibody is typically stored as hybridoma supernatant , which requires specific handling protocols to maintain its activity against arabinogalactan proteins.
When addressing declining antibody reactivity:
Compare with fresh antibody aliquots to distinguish between antibody degradation and changes in the biological system
Examine potential changes in protein expression, modification, or localization
Evaluate technical factors such as extraction efficiency, gel running conditions, or transfer parameters
Consider epitope masking due to protein interactions or modifications
Test antibody performance across a range of concentrations to assess sensitivity shifts
Studies on antibody persistence have shown that antibody reactivity can decline significantly over time, with reductions of 26.5% observed over just three months in some systems . This suggests that researchers should establish regular validation checkpoints in longitudinal studies.
Essential controls include:
To distinguish between cross-reactivity and genuine isoforms:
Compare band patterns with predicted molecular weights of known isoforms
Use knockout/knockdown lines for each suspected isoform
Perform peptide competition assays with isoform-specific peptides
Employ 2D gel electrophoresis to separate isoforms based on both size and charge
Validate findings using mass spectrometry to identify proteins in each band
Understanding the predicted size, modification state, and expression pattern of potential isoforms is critical for accurate interpretation. Additionally, comparing results across multiple antibodies targeting different regions of the protein can provide complementary evidence.
To address inconsistent results:
Evaluate how different techniques might affect epitope accessibility or protein conformation
Optimize protocol parameters specifically for each technique (e.g., fixation for immunohistochemistry vs. extraction for Western blotting)
Consider the oligomeric state of the protein in different experimental contexts
Test multiple antibody concentrations for each technique to identify optimal working ranges
Use complementary non-antibody-based methods to validate findings
Different techniques expose proteins to different conditions that can affect antibody binding. For example, the denaturation in SDS-PAGE might expose epitopes that are inaccessible in native immunoprecipitation, leading to apparently contradictory results despite using the same antibody.
Bispecific antibody applications in plant research:
Simultaneously targeting multiple proteins in complex signaling pathways
Creating proximity-based detection systems for protein-protein interactions
Enhancing detection sensitivity by linking primary recognition to secondary amplification
Developing tools for specific subcellular targeting of experimental payloads
Creating synthetic plant signaling circuits for experimental manipulation
Recent advances in bispecific antibody design, including chain-steering mutations and glycoengineering, provide new opportunities for developing sophisticated research tools . These technologies could be particularly valuable for studying protein complexes and signaling networks in plant systems.
Promising directions include:
Developing smaller antibody fragments with improved tissue penetration
Engineering antibodies with enhanced stability under plant-specific experimental conditions
Creating conformation-specific antibodies to distinguish between active and inactive protein states
Designing antibodies with controlled binding kinetics for specific applications
Developing plant-expressed antibodies for in vivo studies of protein dynamics
Antibody engineering approaches, such as those that modify Fc regions to enhance or reduce effector functions, could be adapted to create improved research tools specific to plant biology questions . These engineered antibodies could overcome traditional limitations in plant cell biology techniques.
Based on studies of antibody persistence:
Experimental designs should account for potential changes in antibody reactivity over time
Validation controls should be incorporated at multiple timepoints in longitudinal studies
Interpretation of apparent differences in protein abundance should consider antibody persistence factors
Storage and handling protocols should be optimized to minimize reactivity loss
Alternative detection methods might be necessary for very long-term studies
Research has shown that antibody prevalence can decline by 26.5% over just three months under certain conditions , suggesting that careful experimental design is essential for accurate interpretation of results in long-term studies of plant immune responses.